Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversität Duisburg-Essen
About this trial
This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.
Eligibility criteria
Qualifiers
Initial treatment with platinum-containing or taxane-based CTX (regardless of the the length of the CTX cycle)
Senological, gynecological or internistic tumors
Phantogeusia (on average ≥4 NRS)
Willingness to participate in the study and written informed consent
Disqualifiers
Severe stomatitis
Dysgeusia before the CTX based on neurological diseases, diabetes, or the ingestion of drugs with taste disorders as side effects
Leucopenia/neutropenia
Intake of anticoagulants
Trial design
Treatments tested in this trial
- Hypoglossal acupuncture
- Sham acupuncture
- Dietary recommendations
Treatment groups
75 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov